Literature DB >> 5763660

Hyperglycemic, nonketotic coma following administration of Dilantin (Diphenylhydantoin).

E M Goldberg, S S Sanbar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5763660     DOI: 10.2337/diab.18.2.101

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  10 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

2.  Hyperosomolar coma in surgical patients: an latrogenic disease of increasing incidence.

Authors:  W I Brenner; Z Lansky; R M Engelman; W M Stahl
Journal:  Ann Surg       Date:  1973-11       Impact factor: 12.969

3.  The role of carbohydrate and oral agents in the treatment of diabetes mellitus.

Authors:  W D Odell
Journal:  Calif Med       Date:  1973-10

4.  Carcinoma of the pancreas and hyperosmolar coma.

Authors:  A G Cudworth
Journal:  Postgrad Med J       Date:  1973-01       Impact factor: 2.401

5.  Focal epilepsy in diabetic non-ketotic hyperglycaemia.

Authors:  C Grant; C Warlow
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20

6.  Ketonaemia in uncontrolled diabetes mellitus.

Authors:  P J Watkins; D M Hill; M G Fitzgerald; J M Malins
Journal:  Br Med J       Date:  1970-11-28

7.  Hyperglycaemia due to phenytoin toxicity.

Authors:  T Treasure; P A Toseland
Journal:  Arch Dis Child       Date:  1971-08       Impact factor: 3.791

Review 8.  The risk-benefit ratio of anticonvulsant drugs.

Authors:  M J Eadie
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

9.  Effect of diphenylhydantoin on patterns of insulin secretion in obese subjects.

Authors:  B Draznin; D Ayalon; E Hoerer; Z Oberman; A Harell; R Ravid; L Laurian
Journal:  Acta Diabetol Lat       Date:  1977 Jan-Apr

Review 10.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.